Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, December 29, 2015
CMC Biologics, Inc. today announced that they have entered into an agreement with Immunocore Limited, a leading UK-based biotechnology company focused on developing new treatments for cancer, viral infections and autoimmune diseases, for the process ...
read more
Hawkins has announced that it recently completed its acquisition of Stauber Performance Ingredients from ICV Partners II, L.P. and its other shareholders in a cash for stock transaction.
read more
Agenus Inc., an immunotherapy company developing innovative treatments for patients with cancer, announced today that it has completed the previously announced acquisition of XOMA Corporation’s antibody manufacturing pilot plant and capabilities.
read more
Cepheid has announced an agreement with Henry Schein Medical, the U.S. Medical business of Henry Schein, Inc., for the distribution of its GeneXpert® System and menu of 17 Xpert® tests spanning healthcare associated infections, critical infectious ...
read more
PharMEDium Services, LLC is voluntarily recalling 29 lots of 4mg Norepinephrine Bitartrate (16mcg/mL) added to 0.9% Sodium Chloride in 250mL Viaflex Bag and 3 lots of 8mg Norepinephrine Bitartrate (32mcg/mL) added to 0.9% Sodium Chloride in 250mL ...
read more
Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on gastrointestinal and cardio-renal diseases, has announced that Paul Korner, MD, MBA, joined the Company in a newly created position as Executive Vice President and Chief Medical ...
read more
NeoGenomics, a provider of cancer-focused genetic testing services, announced today that it has completed the acquisition of Clarient, Inc. and its wholly-owned subsidiary Clarient Diagnostic Services, Inc. Clarient, a provider of comprehensive ...
read more
Wednesday, January 06, 2016
Sterigenics International, a global provider of contract sterilization, gamma technologies and medical isotopes, has announced expansion at their Forth Worth, Texas location, with the addition of a new gamma cell that will increase capacity by 30%.
read more
Wednesday, January 06, 2016
Rodin Therapeutics, a biotechnology company applying insights from epigenetics to develop novel therapeutics for neurological disorders, today announced preferred stock financing commitments totaling $17.3M from Atlas Venture and Biogen. In addition ...
read more
Wednesday, January 06, 2016
Takeda Pharmaceutical has announced the acquisition of a biologics manufacturing facility located in Brooklyn Park, Minnesota, U.S. from Baxalta US Inc.
read more
Wednesday, January 06, 2016
X-Chem, Inc., a privately held biotechnology company applying its cutting-edge lead discovery capabilities to the generation of novel small molecule therapeutics, announced a multi-target collaboration with Sanofi.
read more
Wednesday, January 06, 2016
Capsugel has completed its acquisitions of Xcelience and Powdersize. Xcelience and Powdersize are now part of Capsugel's Dosage Form Solutions business unit, which partners with pharmaceutical and health and nutrition customers around the world.
read more
Wednesday, January 06, 2016
Voisin Consulting Life Sciences, a global healthcare product development consultancy, and iQone Healthcare, a specialty pharmaceutical company focused on pharmaceutical distribution, sales, marketing and contract services in Europe, have announced a ...
read more
WuXi AppTec Co. Ltd. has started construction of a state-of-the-art integrated biologics solution center at the company's headquarters in Shanghai. The company plans to invest a total of $120 million in this dedicated, 250,000-square-foot facility, ...
read more
Recipharm has appointed Yves Buelens to the position of General Manager for its wholly owned new subsidiary Kaysersberg Pharmaceuticals SAS.
read more